CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Is tenofovir monotherapy a sufficient defense line against multi-drug resistant hepatitis B virus?
Yun Bin Lee, Jeong-Hoon Lee
Clin Mol Hepatol. 2017;23(3):219-221.   Published online 2017 September 19    DOI: https://doi.org/10.3350/cmh.2017.0045

Excel Download

Is tenofovir monotherapy a sufficient defense line against multi-drug resistant hepatitis B virus?
Clinical and Molecular Hepatology. 2017;23(3):219-221   Crossref logo
Link1 Link2 Link3

495 Tenofovir (TNV) has stronger antiviral effect than adefovir dipivoxil (ADV) against lamivudine (LAM) resistant hepatitis B virus (HBV)
Journal of Hepatology. 2006;44:S184-S185   Crossref logo
Link1 Link2

Tenofovir (TDF) has stronger antiviral effect than adefovir (ADV) against lamivudine (LAM)-resistant hepatitis B virus (HBV)
Hepatology International. 2008;2(2):244-249   Crossref logo
Link1 Link2 Link3

Efficacy of Combination Tenofovir Plus Lamivudine Versus Tenofovir Monotherapy in Patients With Chronic Hepatitis B Virus
Gastroenterology. 2011;140(5):S-455   Crossref logo
Link1 Link2

Tenofovir-alafenamide withdrawal
Reactions Weekly. 2022;1908(1):519-519   Crossref logo
Link1 Link2 Link3

Long-Term Efficacy of Tenofovir Monotherapy for Hepatitis B Virus-Monoinfected Patients After Failure of Nucleoside/Nucleotide Analogues
Yearbook of Gastroenterology. 2010;2010:232-233   Crossref logo
Link1 Link2

P062: A randomized comparative open label trial of tenofovir monotherapy versus tenofovir plus telbuvidine dual therapy in spontaneous reactivation of hepatitis B (NCT01732224)
Journal of Viral Hepatitis. 2015;22:51-51   Crossref logo
Link1 Link2 Link3

HBV3 O-29: A randomized comparative open label trial of tenofovir monotherapy versus tenofovir plus telbuvidine dual therapy in spontaneous reactivation of hepatitis B (NCT01732224)
Journal of Viral Hepatitis. 2015;22:17-18   Crossref logo
Link1 Link2 Link3

Tenofovir plus lamivudine as rescue therapy for adefovir-resistant chronic hepatitis B in hepatitis B e antigen-positive patients with liver cirrhosis
Liver International. 2008;28(6):814-820   Crossref logo
Link1 Link2

FRI-216-Tenofovir monotherapy versus tenofovir plus entecavir combination therapy for multi-drug resistant chronic hepatitis B: Five year follow-up data of multicenter prospective cohort study (Final results)
Journal of Hepatology. 2019;70(1):e489   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.